Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 1 of 2612345...1020...Last »

More Evidence Linking Sugared Drinks To Diabetes

A new study uncovers some potentially important new details about the association between sugared drinks and diabetes. In a paper published in Diabetologia [pdf], researchers in the UK report on a study of more than 25,000 adults. Over the course of more than 10 years of followup 847 participants went on to develop diabetes. Instead of relying on a […]

Read More »

5 Reasons The Affordable Care Act Will Be Good For Americans

In October, 2013, at the launch of the Affordable Care Act, I predicted that the health insurance exchanges about to go into effect would grow in popularity and  improve the health insurance marketplace, then so imperfect. Twenty months later, the exchanges are proving effective in reducing the number of uninsured and are beginning to provide […]

Read More »

CRISPR: The Technology Behind Human Embryo Editing

The startling research paper detailing the first-ever attempt to edit the genome of human embryos has aroused a great deal of interest and some alarm, but the nature of the DNA editing technique, known as CRISPR, is not so widely known. Also not so widely known is the technique’s peculiar history, which shows again how […]

Read More »

FDA Approves BREO ELLIPTA for the Treatment of Adults With Asthma in the US

LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA–(Marketwired – Apr 30, 2015) – GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved BREO® ELLIPTA® (fluticasone furoate/vilanterol [FF/VI]) for the once-daily treatment of asthma in patients aged 18 years and older. Breo Ellipta is […]

Read More »

Gilead first-quarter profit doubles on strong hepatitis C drug sales

(Reuters) – Gilead Sciences Inc on Thursday said its quarterly profit nearly doubled, driven by strong sales of its hepatitis C drugs, as it topped Wall Street estimates. Gilead signaled that, with its hepatitis C franchise established, it is a good time for the company to consider business development opportunities. “We want to stick very […]

Read More »

FDA approves Glaxo, Theravance’s Breo Ellipta asthma drug

(Reuters) – The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and Theravance Inc said.   The FDA declined to approve Breo for younger asthma sufferers. The agency, in a so-called complete response letter, told the companies […]

Read More »

FDA approves Medicines Co’s blood-clotting agent

(Reuters) – The U.S. Food and Drug Administration on Thursday approved The Medicines Co’s dry powder blood-clotting agent for use in hospital settings, a month after the treatment received approval in Europe. The treatment, Raplixa, is a combination of two human plasma-derived blood-clotting proteins – fibrinogen and thrombin. ( Raplixa is used to control bleeding […]

Read More »

FDA approves the Medicines Co’s pain drug device Ionsys

(Reuters) – The U.S. Food and Drug Administration approved the Medicines Co’s drug device, Ionsys, for postoperative pain for hospital use, the company said on Thursday. Ionsys – a needleless, patient-controlled opioid-based treatment – offers patients recovering from surgery in the hospital control over their analgesic dosing. Ionsys was originally developed by Johnson & Johnson […]

Read More »

FDA approves BREO ELLIPTA for the treatment of adults with asthma in the US

LONDON and SAN FRANCISCO, April 30, 2015 /PRNewswire/ — GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved BREO® ELLIPTA® (fluticasone furoate/vilanterol [FF/VI]) for the once-daily treatment of asthma in patients aged 18 years and older. Breo Ellipta is not indicated for the […]

Read More »

What AMC’s Mad Men Tells Us About Healthcare

One of the striking features of the early episodes of AMC’s hit television show Mad Men is the similarities in the lifestyle enjoyed by the lowest paid members of Don Draper’s advertising company and its wealthy partners. In the show’s 1960s setting, regardless of class, these folks largely lived in similar homes, went to the same […]

Read More »

Obamacare Exchanges Attracting Younger Customers, Insurers Say

As health insurance companies tally up the second year of enrollment of individuals from public exchanges under the Affordable Care Act, they are noticing younger customers that tend to submit fewer medical claims. Several insurance companies, including Aetna (AET) and Anthem (ANTM), this week during their first quarter earnings calls said those purchasing subsidized coverage […]

Read More »

AMERIGEN Announces Tentative Approval of Generic Toviaz

LYNDHURST, N.J., April 30, 2015 /PRNewswire/ — Amerigen Pharmaceuticals Limited today announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval to the Company’s Abbreviated New Drug Application (ANDA) for a generic version of Toviaz® (Fesoterodine Fumarate Extended-release Tablets, 4mg and 8mg).  Based upon available information, Amerigen believes that it is a first […]

Read More »

Merus Labs International Inc. announces closing of c$60.0 million bought deal financing

TORONTO, April 30, 2015 /PRNewswire/ – Merus Labs International Inc. (“Merus” or the “Company“) (TSX: MSL, NASDAQ: MSLI) is pleased to announce today the closing of its previously announced bought deal financing with a syndicate of investment dealers (the “Underwriters“). Under the financing, Merus issued a total of 19,672,200 common shares (“Shares“) at a price […]

Read More »

Eisai and Glenmark Reach Settlement over Generic Version of BANZEL (rufinamide)

WOODCLIFF LAKE, N.J., April 30, 2015 /PRNewswire/ — Eisai Inc. and Eisai Co., Ltd. have entered into a settlement agreement with Glenmark Pharmaceuticals, Ltd., Glenmark Generics Ltd., and Glenmark Generics, Inc., USA (“Glenmark”), to resolve their patent litigation relating to Eisai’s BANZEL® (rufinamide) in the United States. As a result of the settlement, Glenmark will be […]

Read More »

PlugMed Has Been Awarded €2 Million of Funding for an Innovative Device in the Treatment of Kidney Failure

PARIS & ROUEN, France–(BUSINESS WIRE)–PlugMed has been awarded €2 million of funding, as part of the World Innovation Challenge organized by the French Ministry of Industry. The funding will enable the company to speed up the Geroneph project that aims at developing an innovative device in the treatment of kidney failure. PlugMed designs, develops and […]

Read More »

Intertek Vice President of Chemical Services Sherri Bassner Joins Board of Industrial Research Institute

CHICAGO–(BUSINESS WIRE)–Intertek (LSE: ITRK), a leading provider of quality and safety services to a wide range of industries around the world, today announced that Sherri Bassner has been elected to the board of directors of the Industrial Research Institute (IRI). She joined the 12-member board yesterday during an official initiation at IRI’s Annual Meeting in […]

Read More »

Ketchum and World Hepatitis Alliance’s World Hepatitis Day Campaign Named PRWeek’s Global Non-profit Campaign of the Year

LONDON, April 30, 2015 /PRNewswire/ — Leading global public relations firm Ketchum, in partnership with the World Health Organization and World Hepatitis Alliance, received the PRWeek Global Award for Non-profit Campaign of the Year for its World Hepatitis Day campaign. This award, along with a high commendation for the campaign in the Global PR Breakthrough of the […]

Read More »

FDA seeks more data on antiseptic ingredients

The corporate logo of the U.S. Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, 2009. Reuters/Jason Reed (Reuters) – The U.S. Food and Drug Administration said it has asked for additional data to support the continued safety and effectiveness of certain active ingredients in antiseptics sold over the counter to […]

Read More »

Many patients unaware of risks that go with some medical scans

A X-ray of a patient with a lung tumour caused by smoking is seen at Ruijin Hospital in Shanghai April 27, 2011. Reuters/Carlos Barria (Reuters Health) – Over half of people receiving medical scans such as X-rays do not know if they are exposed to radiation and many have unanswered questions even as they are […]

Read More »

Jeff Poulton Appointed Shire Chief Financial Officer and Joins Board of Directors

Dublin, Ireland– April 30, 2015 – Shire plc (LSE: SHP, NASDAQ: SHPG) announces the appointment of Jeff Poulton as Chief Financial Officer (CFO) and member of the Executive Committee. Jeff will additionally join the Shire Board of Directors. Both appointments are effective immediately.  Jeff has served as Interim CFO since December 2014, while overseeing Investor […]

Read More »

Page 1 of 2612345...1020...Last »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom